Key statistics
As of last trade Vera Therapeutics Inc (VERA:NMQ) traded at 39.37, -29.76% below its 52-week high of 56.05, set on Dec 24, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 39.31 |
|---|---|
| High | 40.12 |
| Low | 39.01 |
| Bid | 39.37 |
| Offer | 39.57 |
| Previous close | 40.42 |
| Average volume | 1.05m |
|---|---|
| Shares outstanding | 71.36m |
| Free float | 69.12m |
| P/E (TTM) | -- |
| Market cap | 2.88bn USD |
| EPS (TTM) | -4.66 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 16:04 GMT.
More ▼
- Vera Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results
- Vera Therapeutics to Participate at Upcoming Investor Conferences
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics Announces Appointment of Matt Skelton to Chief Commercial Officer
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
- Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
- Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
- Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
